NDRA News and Press, ENDRA Life Sciences Inc. From 03/31/22

ISO 13485 Recertification Affirms Quality Standards Supporting ENDRA’s CE Mark ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces receipt of Medical Device Quality Management System ISO 13485:20...

ENDRA Life Sciences, Inc. (NDRA) Q4 2021 Earnings Conference Call March 30, 2022 04:30 PM ET Company Participants Yvonne Briggs - IR Francois Michelon - Chairman and CEO Renaud Maloberti - CCO Irina Pestrikova - Senior Director, Finance Conference Call Participants Ed Woo - Ascendiant Capital...

Endra Life Sciences press release (NASDAQ:NDRA): FY GAAP EPS of -$0.28. As of December 31, 2021, ENDRA had cash and cash equivalents of $9.5 million.  Shares +5%. For further details see: Endra Life Sciences GAAP EPS of -$0.28

Conference call begins at 4:30 p.m. Eastern time today ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), today reported financial results for the three months and year ended December 31, 2021 and provided a bus...

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces that the Chinese National Intellectual Property Administration has issued ENDRA two new patents, Chinese Patent No. ZL 2019 8 00400927 (the ‘927 pa...

Endra Life Sciences (NASDAQ:NDRA) is scheduled to announce Q4 earnings results on Wednesday, March 30th, after market close. The consensus EPS Estimate is -$0.08 (+87.3% Y/Y) and the consensus Revenue Estimate is $0.23M Over the last 3 months, EPS estimates have seen 0 upward revisions&#...

AESE, AGRX, BEEM, EDAP, GNLN, ISUN, IZEA, KBNT, KMPH, NDRA, OEG, PATH, PHR, RKDA, STON, OTCQX:TLLTF, USWS, VNET For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Wednesday's close

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the fourth quarter of 2021 on Wednesday, March 30, 2022 after the close of trading on the U.S. financial markets. Manage...

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces that management will participate in two investor conferences during March: 34 th Annual ROTH Conference, March 13-15, 2022 at The Ritz-Carlton Laguna ...

Endra Life Sciences (NDRA -1.6%) said the U.S. Patent and Trademark Office issued a new patent related to its Thermo Acoustic Enhanced UltraSound (TAEUS) system. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Diseas...